Bangkok Post - May 4, 2007
Apiradee Treerutkuarkul
Prime Minister Surayud Chulanont is confident the government can explain to the world why compulsory licensing of patented foreign medicines is necessary.
The government also claims to have received many messages of support from foreigners who support the policy.
"We stand by what we have done, and we can explain our actions to the world community," he said.
Thai officials needed to work with US officials and resolve the dispute over the decision by the US Trade Representative Office to downgrade Thailand to a country deemed to have poor intellectual property protection.
Gen Surayud said the Commerce Ministry would handle copyright and intellectual property violations.
The need to uncover any link between ousted prime minister Thaksin Shinawatra and the USTR's decision was secondary to explaining the need to use compulsory licensing.
Public Health Minister Mongkol Na Songkhla said he had received more than 200 letters and email messages from foreigners showing their support for Thailand's compulsory licensing of generic versions of the Aids medications Efavirenz and Kaletra and the heart drug Plavix.
The minister insisted the government acted with good intentions, of giving the poor access to inexpensive and quality medical treatment.
He would travel to the US along with Vichai Chokewiwat, chairman of the Government Pharmaceutical Organisation board, who would sign a contract with the foundation run by former US president Bill Clinton.
The Clinton Foundation would help Thailand negotiate with Aids drug makers in the US to ensure that the price of medicines was affordable for HIV/Aids patients.
Council for National Security chairman Gen Sonthi Boonyaratkalin said he had no information about Mr Thaksin's supposed link to Thailand's downgrading by the USTR.
He also rejected a US critic's comment that Thailand cannot afford to buy Aids drugs because much of the national budget had gone on funding the army.
Gen Sonthi said the army had its own annual budget, and had not taken other agencies' money.
Health activists yesterday protested outside the US embassy against Washington's decision to put Thailand on the priority watch list.
Virat Poorahong, leading the Thai Network of People Living with HIV/Aids, believed the US move was in response to the government's enforcement of compulsory licensing, even though the US ambassador had said compulsory licensing was just one concern, but not the main reason.
However, an expert on international trade law at the University of Wollongong in Australia, Jakkrit Kuanpoth, said the government should not be too worried about the priority watch list.
It was less serious than the priority foreign countries list under the US Omnibus Trade and Competitiveness Act, which provides for trade retaliation measures, he said.
070504
BP070503
Copyright © 2007 - The Bangkok Post. Reproduction of this article (other than one copy for personal reference) must be cleared through the Bangkok Post.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .